⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9051936 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL11564395 | 0.97 | — | — | |
| SCHEMBL28137648 | 0.91 | — | — | |
| Formic Acid SCHEMBL31492467 | 0.88 | — | — | |
| SCHEMBL3457631 | 0.84 | HDAC3 (0.44) | — | |
| SCHEMBL3458183 | 0.80 | GABRR1 (0.44) | — | |
| SCHEMBL3459156 | 0.80 | HDAC8 (0.41) | — | |
| SCHEMBL14617480 | 0.78 | — | — | |
| SCHEMBL31107449 | 0.76 | — | — | |
| SCHEMBL389017 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 554 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080902-A | Composition with oil displacement function, application thereof and thickened oil exploitation method | — | 2026-05-26 | — | — | CN | claimed |
| EP-4656189-A1 | COMPOUND AND USE THEREOF | Benethera (Shaoxing) Biotechnology Co., Ltd. (CN) | 2025-12-03 | — | — | EP | claimed |
| CN-120157685-A | Oxygen bridge bicyclo- [2.2.1] heptene estrogen receptor macrocyclic compound with different linkers, and preparation method and application thereof | 湖北大学 | 2025-06-17 | — | — | CN | claimed |
| EP-3935041-B1 | INTEGRATED METHODS AND SYSTEMS FOR PRODUCING AMIDE AND NITRILE COMPOUNDS | NOVOMER INC (US) | 2025-04-09 | — | — | EP | claimed |
| CN-118593890-A | Band-aid type microneedle patch for glucose monitoring and photo-thermal response drug delivery and preparation method thereof | 山东大学 | 2024-09-06 | — | — | CN | claimed |
| CN-118221408-A | Preparation method and application of high-freezing-resistance hydrophobic functional foam concrete | 中交第一航务工程局有限公司 | 2024-06-21 | — | — | CN | claimed |
| WO-2023227695-A1 | NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS | KATHOLIEKE UNIVERSITEIT LEUVEN (BE) | 2023-11-30 | — | — | WO | claimed |
| WO-2023219456-A1 | QUINOLINE-BASED HISTONE DEACETYLASE INHIBITORY SUBSTANCES, PREPARATION METHOD THEREFOR, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME AS ACTIVE INGREDIENT | 숙명여자대학교 산학협력단 | 2023-11-16 | — | — | WO | claimed |
| CN-117043157-A | ERAP inhibitors | 里尔大学 | 2023-11-10 | — | — | CN | claimed |
| CN-114272900-B | Solid phase extractant, preparation method and application thereof | 杭州景业智能科技股份有限公司 | 2023-08-15 | — | — | CN | claimed |
| US-20080161325-A1 | e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome | ELAN PHARMACEUTICALS, INC. | 2008-07-03 | — | — | US | claimed |
| US-20070155730-A1 | Benzodiazepine And Benzopiperazine Analog Inhibitors Of Histone Deacetylase | METHYLGENE, INC. (CA) | 2007-07-05 | — | — | US | claimed |
| WO-2006107980-A2 | COMPOSITIONS AND METHODS TO ELIMINATE ODORS | ECO-PETS, LLC (US) | 2006-10-12 | — | — | WO | claimed |
| WO-2005077937-A1 | SUBSTITUTED HYDROXAMIC ACID DERIVATIVES AS TNF INHIBITORS | CADILA HEALTHCARE LIMITED (IN) | 2005-08-25 | — | — | WO | claimed |
| US-20040171543-A1 | Matrix metalloproteinase inhibitors and methods for identification of lead compounds | WARNER-LAMBERT COMPANY LLC | 2004-09-02 | — | — | US | claimed |
| US-20040110729-A1 | Primary N-hydroxylamines | NIH | 2004-06-10 | — | — | US | claimed |
| WO-2004014381-A2 | MATRIX METALLOPROTEINASE INHIBITORS AND METHODS FOR IDENTIFICATION OF LEAD COMPOUNDS | WARNER-LAMBERT COMPANY LLC. (US) | 2004-02-19 | — | — | WO | claimed |
| US-6455589-B1 | AN ORALLY ADMINISTRABLE EFFECTIVE UNIT SOLID DOSAGE OF A PRIMARY N-HYDROXYLAMINE OR A SALT, FREE OF NITRONE; USEFUL FOR REDUCING OXIDATIVE DAMAGE OR DELAYING SENESCENCE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2002-09-24 | — | — | US | claimed |
| CN-1252790-A | N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors | AMERICAN CYANAMID CO (US) | 2000-05-10 | — | — | CN | claimed |
| EP-0009776-B1 | N-MONOHYDROXYPROPYLAMIDES, N-DIHYDROXYPROPYLAMIDES AND THEIR ACETONOIDES OF ALL-E AND 13-Z RETINOIC ACID, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BASF Aktiengesellschaft (DE) | 1982-07-28 | — | — | EP | claimed |